Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
- PMID: 32345247
- PMCID: PMC7189724
- DOI: 10.1186/s12880-020-00433-y
Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
Abstract
Background: To evaluate the utility of non-invasive parameters derived from T1 mapping and diffusion-weighted imaging (DWI) on gadoxetic acid-enhanced MRI for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC).
Methods: A total of 94 patients with single HCC undergoing partial hepatectomy was analyzed in this retrospective study. Preoperative T1 mapping and DWI on gadoxetic acid-enhanced MRI was performed. The parameters including precontrast, postcontrast and reduction rate of T1 relaxation time and apparent diffusion coefficient (ADC) values were measured for differentiating MVI-positive HCCs (n = 38) from MVI-negative HCCs (n = 56). The receiver operating characteristic curve (ROC) was analyzed to compare the diagnostic performance of the calculated parameters.
Results: MVI-positive HCCs demonstrated a significantly lower reduction rate of T1 relaxation time than that of MVI-negative HCCs (39.4% vs 49.9, P < 0.001). The areas under receiver operating characteristic curve (AUC) were 0.587, 0.728, 0.824, 0,690 and 0.862 for the precontrast, postcontrast, reduction rate of T1 relaxation time, ADC and the combination of reduction rate and ADC, respectively. The cut-off value of the reduction rate and ADC calculated through maximal Youden index in ROC analyses was 44.9% and 1553.5 s/mm2. To achieve a better diagnostic performance, the criteria of combining the reduction rate lower than 44.9% and the ADC value lower than 1553.5 s/mm2 was proposed with a high specificity of 91.8% and accuracy of 80.9%.
Conclusions: The proposed criteria of combining the reduction rate of T1 relaxation time lower than 44.9% and the ADC value lower than 1553.5 s/mm2 on gadoxetic acid-enhanced MRI holds promise for evaluating MVI status of HCC.
Keywords: Gd-EOB-DTPA; Hepatocellular carcinoma; Magnetic resonance imaging; Microvascular invasion.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The Combination of Gd-EOB-DTPA Enhanced T1 Mapping with Apparent Diffusion Coefficient could Improve the Diagnostic Efficacy of Hepatocellular Carcinoma Grading.Curr Med Imaging. 2024;20:e15734056259418. doi: 10.2174/0115734056259418231112102249. Curr Med Imaging. 2024. PMID: 38918998
-
Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation.Contrast Media Mol Imaging. 2018 Jan 23;2018:9674565. doi: 10.1155/2018/9674565. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 29606926 Free PMC article. Clinical Trial.
-
Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?J Gastroenterol Hepatol. 2014 Feb;29(2):330-6. doi: 10.1111/jgh.12358. J Gastroenterol Hepatol. 2014. PMID: 24033853
-
Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.Liver Transpl. 2017 Dec;23(12):1505-1518. doi: 10.1002/lt.24867. Liver Transpl. 2017. PMID: 28886231 Review.
-
Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.J Gastroenterol Hepatol. 2018 Feb;33(2):347-354. doi: 10.1111/jgh.13843. J Gastroenterol Hepatol. 2018. PMID: 28589639 Review.
Cited by
-
Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma.Front Oncol. 2023 Jun 30;13:1134646. doi: 10.3389/fonc.2023.1134646. eCollection 2023. Front Oncol. 2023. PMID: 37456233 Free PMC article.
-
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques.J Gastrointest Cancer. 2024 Dec;55(4):1469-1484. doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19. J Gastrointest Cancer. 2024. PMID: 39158837 Review.
-
Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators.Front Oncol. 2023 Jan 19;12:1068231. doi: 10.3389/fonc.2022.1068231. eCollection 2022. Front Oncol. 2023. PMID: 36741705 Free PMC article.
-
Magnetic resonance elastography can predict the development of hepatocellular carcinoma: a meta-analysis and systematic review.J Gastrointest Oncol. 2021 Aug;12(4):1215-1222. doi: 10.21037/jgo-21-196. J Gastrointest Oncol. 2021. PMID: 34532081 Free PMC article.
-
Diagnostic value of magnetic resonance imaging features of microvascular invasion in hepatocellular carcinoma: a meta-analysis.Diagn Interv Radiol. 2022 Sep;28(5):428-440. doi: 10.5152/dir.2022.21108. Diagn Interv Radiol. 2022. PMID: 36218148 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
